U.S. Digital Therapeutics Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Table Of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Estimates and Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary sources
                       1.3.4 Primary Research
                       1.3.5 Details of Primary Research
                           1.3.5.1 Data for primary interviews in the U.S.
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation and Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                   1.7 List of Secondary Sources
                   1.8 Report Objectives
Chapter 2 Executive Summary
                   2.1 Market Outlook
                       2.1.1 U.S. Digital Therapeutics market Outlook, 2016 - 2027 (USD Million)
                   2.2 U.S. Digital Therapeutics Market Summary, 2019
Chapter 3 Market Variables, Trends, and Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market analysis
                       3.1.2 Ancillary market Analysis
                   3.2 Penetration and Growth Prospect Mapping
                       3.2.1 Market driver analysis
                           3.2.1.1 Increasing smartphone penetration
                           3.2.1.2 Cost-effectiveness of digital health technology for providers and patients
                           3.2.1.3 Increasing demand for integrated healthcare systems and patient-centric care
                       3.2.2 Market restraint analysis
                           3.2.2.1 Reimbursement scenario
                   3.3 U.S. Digital Therapeutics Market Analysis Tools: Porters
                   3.4 PESTEL Analysis
Chapter 4 U.S. Digital Therapeutics Market: Competitive Analysis
                   4.1 Key Company Market Share Analysis, 2019 (Estimated)
                   4.2 Market Leaders
                   4.3 Innovators
                       4.3.1 Pear Therapeutics
                       4.3.2 Livongo Health
                       4.3.3 Omada Health, inc.
                       4.3.4 Propeller health
                   4.4 Major Deals & Strategic Alliances Analysis
Chapter 5 Impact of COVID-19
                   5.1 Current and Future Impact Analysis
                   5.2 Disease Prevalence Analysis (January to May 2020)
                   5.3 Impact on Mental Health
                   5.4 Impact on People with Chronic Diseases
                   5.5 Opportunity Analysis
                   5.6 List of private companies
Chapter 6 Application Estimates & Trend Analysis
                   6.1 Application Market Share Analysis, 2019 & 2027
                   6.2 Application Dashboard
                   6.3 Diabetes
                       6.3.1 Diabetes market estimates and forecasts, 2016 - 2027 (USD Million)
                   6.4 Obesity
                       6.4.1 Obesity market estimates and forecasts, 2016 - 2027 (USD Million)
                   6.5 Cardiovascular Diseases (CVD)
                       6.5.1 CVD market estimates and forecasts, 2016 - 2027 (USD Million)
                   6.6 CNS diseases
                       6.6.1 CNS diseases market estimates and forecasts, 2016 - 2027 (USD Million)
                   6.7 Respiratory Diseases
                       6.7.1 Respiratory diseases market estimates and forecasts, 2016 - 2027 (USD Million)
                   6.8 Smoking Cessation
                       6.8.1 Smoking Cessation market estimates and forecasts, 2016 - 2027 (USD Million)
                   6.9 Others
                       6.9.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 7 End-use Estimates & Trend Analysis
                   7.1 End-use Market Share Analysis, 2019 & 2027
                   7.2 End-use Dashboard
                   7.3 Patients
                       7.3.1 Patients market estimates and forecasts, 2016 - 2027 (USD Million)
                   7.4 Providers
                       7.4.1 Providers market estimates and forecasts, 2016 - 2027 (USD Million)
                   7.5 Payers
                       7.5.1 PAYERS market estimates and forecasts, 2016 - 2027 (USD Million)
                   7.6 Employers
                       7.6.1 Employers market estimates and forecasts, 2016 - 2027 (USD Million)
                   7.7 Others
                       7.7.1 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 8 Company Profiles
                   8.1 Proteus Digital Health, Inc.
                       8.1.1 Company overview
                       8.1.2 Financial performance
                       8.1.3 Product benchmarking
                       8.1.4 Strategic initiatives
                   8.2 Omada Health, Inc.
                       8.2.1 Company overview
                       8.2.2 Financial performance
                       8.2.3 Product benchmarking
                       8.2.4 Strategic initiatives
                   8.3 Livongo Health, Inc.
                       8.3.1 Company Overview
                       8.3.2 Financial Performance
                       8.3.3 Product Benchmarking
                       8.3.4 Strategic Initiatives
                   8.4 2Morrow, Inc.
                       8.4.1 Company Overview
                       8.4.2 Financial Performance
                       8.4.3 Product Benchmarking
                       8.4.4 STRATEGIC INITIATIVES
                   8.5 Propeller Health
                       8.5.1 Company Overview
                       8.5.2 Financial PERFORMANCE
                       8.5.3 Product Benchmarking
                       8.5.4 Strategic Initiatives
                   8.6 Fitbit, Inc. 
                       8.6.1 Company Overview
                       8.6.2 Financial Performance
                       8.6.3 Product Benchmarking
                       8.6.4 STRATEGIC INITIATIVES
                   8.7 Canary Health
                       8.7.1 Company Overview
                       8.7.2 Financial Performance
                       8.7.3 Product Benchmarking
                       8.7.4 Strategic Initiatives
                   8.8 Mango Health
                       8.8.1 Company Overview
                       8.8.2 Financial Performance
                       8.8.3 Product Benchmarking
                       8.8.4 STRATEGIC INITIATIVES
                   8.9 WellDoc, Inc.
                       8.9.1 Company Overview
                       8.9.2 Financial Performance
                       8.9.3 Product Benchmarking
                       8.9.4 Strategic Initiatives
                   8.10 Noom, Inc
                       8.10.1 Company Overview
                       8.10.2 Financial Performance
                       8.10.3 Product Benchmarking
                       8.10.4 STRATEGIC INITIATIVES
                   8.11 Pear Therapeutics
                       8.11.1 Company Overview
                       8.11.2 Financial Performance
                       8.11.3 Product Benchmarking
                       8.11.4 STRATEGIC INITIATIVES
                   8.12 Click Therapeutics, Inc.
                       8.12.1 Company overview
                       8.12.2 Financial performance
                       8.12.3 Product benchmarking
                       8.12.4 Strategic initiatives
                   8.13 Akili Interactive Labs, Inc.
                       8.13.1 Company overview
                       8.13.2 Financial performance
                       8.13.3 Product benchmarking
                       8.13.4 Strategic initiatives
                   8.14 Better Therapeutics, LLC
                       8.14.1 Company overview
                       8.14.2 Financial performance
                       8.14.3 Product benchmarking
                       8.14.4 Strategic initiatives

Report Details

  • Report Code:35159
  • Category:Healthcare
  • No. of Pages:200
  • Format:PDF/PPT/Excel
  • Published:November 2020
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers